Insurers paid for anti-parasite drug as a treatment for COVID-19 despite lack of evidence surrounding its effectiveness, according to a new study.
Join The Ecosystem
Insurers paid for anti-parasite drug as a treatment for COVID-19 despite lack of evidence surrounding its effectiveness, according to a new study.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.